The British Gynaecological Cancer Society has issued the first Endometrial (Uterine) Cancer guidelines as recommendation for practice for the UK.

No abstract

No abstract

Surgery with utilisation of cytoreductive procedures to achieve complete clearance should be offered to all patients even after ≥5 cycles if R0 can be achieved. R1 cytoreduction has questionable value in those receiving ≤4 cycles and no value in those receiving ≥5 cycles.

Gynecological cancer surgical throughput can be maintained in COVID-19 pandemic.• A carefully executed mitigation plan ensures patients' safety is maintained.• A COVID-19-free care pathway minimizes risks of COVID-19 transmission.• Post-operative morbidity increases in COVID-19 pandemic.• Concerted effort is required to ensure continuity of surgical training.

Denominator data is critical to understanding selection and OS in AOC. Published outcomes of selected cohorts should routinely incorporate outcomes for all women managed within the reporting Centre. This is essential for benchmarking and quality assurance in gynaecological cancer and should be an integral part of any publication on outcomes from AOC.

Objective: To investigate quality of life (QoL) and association with surgical complexity and disease burden after surgical resection for advanced ovarian cancer in centres with variation in surgical approach.

Multiple bowel resection is the best predictor of morbidity and is more predictive than 'ultra-radical surgery'.